Insiders Bet on a Biotech Bounce

JC Parets
May 23, 2022

ValueAct Partners revealed an additional purchase of roughly $10 million in Insight Enterprises $NSIT, as the activist hedge fund continues to build a position in the enterprise cloud company.

The firm now owns more than 3.8 million shares for a total ownership interest of just under 11%.

The executive chairman of Avis Budget Group $CAR revealed a purchase of approximately 26,000 shares of his company's stock in a Form 4 filing.

Here’s The Hot List, with data through May 20, 2022:

In another Form 4, a Prologis $PLD director reported a $1.7 million purchase in the industrial REIT.

Broad Bay Capital Management LP revealed an ownership stake of 5.6% in MediaAlpha $MAX in a 13G.

There was a lot of insider activity in biotechnology names last week, as Repare Therapeutics $RPTX, Humanigen $HGEN, and Enochian Biosciences $ENOB each had a sizable Form 4 purchase reported Friday.

In the options market, there was bullish flow in the retail chain Kohl's Corporation $KSS and the medical devices company Boston Scientific $BSX.

There was also bullish options activity in the footwear and accessories company Steven Madden $SHOO.

Stay tuned. We'll be back Tuesday with more insider action.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under: